Form 4: IMAX Executive Sells Shares After Option Exercise
Insider Transaction Report
IMAX Deputy GC Kenneth Weissman exercised stock options and subsequently sold a portion of his common shares.
Summary
- Kenneth Ian Weissman, Deputy General Counsel, Corporate Secretary, and Chief Compliance Officer of IMAX Corp., engaged in stock transactions on August 14, 2025.
- Mr. Weissman exercised 7,072 stock options at a price of $22.49 per share, converting them into common shares.
- Following the exercise, he sold 7,072 common shares at an average price of $25.6707 per share.
- An additional 8,000 common shares were sold at an average price of $25.6272 per share.
- The stock options exercised were originally issued in 2019 and are set to expire on March 7, 2026.
- These options became exercisable in four installments: 1,414 shares on March 7, 2020; 1,768 shares on March 7, 2021; 1,768 shares on March 7, 2022; and 2,122 shares on March 7, 2023.
- After these transactions, Mr. Weissman's aggregate direct beneficial ownership stands at 26,133 common shares and 17,021 restricted share units.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of an insider transaction (exercise of options and sale of shares). It does not inherently indicate positive or negative company performance, but rather an executive's personal financial activity. The sale of shares could be interpreted slightly negatively by some, but it's a common practice for liquidity or tax purposes after option exercise.
Positives
- The executive's exercise of stock options at $22.49 and subsequent sale of shares at higher prices ($25.6707 and $25.6272) indicates a profitable transaction for the individual.
Negatives
- The net effect of the transactions is a reduction in the reporting person's direct common share holdings, which can sometimes be perceived as a neutral to slightly negative signal by the market, though often for personal financial planning.
Future Outlook
The stock options exercised were issued in 2019 and are set to expire on March 7, 2026.
Industry Context
This filing is a routine disclosure of an executive's personal stock transactions and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The sale of shares by an executive could lead to minor, short-term negative sentiment, but is generally viewed as a routine event for personal financial management rather than a signal of company performance.
Key Dates
| Date | Description |
|---|---|
| 03/07/2020 | First installment of stock options (1,414 shares) became exercisable. |
| 03/07/2021 | Second installment of stock options (1,768 shares) became exercisable. |
| 03/07/2022 | Third installment of stock options (1,768 shares) became exercisable. |
| 03/07/2023 | Fourth installment of stock options (2,122 shares) became exercisable. |
| 08/14/2025 | Date of stock option exercise and common share sales. |
| 03/07/2026 | Expiration date of the stock options. |
Keywords
IMAX, Insider Trading, Stock Options, Share Sale, Executive Compensation, Form 4, Kenneth Weissman, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.